MILTENYI BIOTEC

Company Snapshot

Founded: 1989
Entity Type: Private
Employees: 5,000
Region: Germany
Headquarter: Bergisch Gladbach, Germany
Key Geographics: North America, Europe, Asia-Pacific
Corporate Address: Friedrich-Ebert-Straße 68 51429 Bergisch Gladbach Germany Tel. +49-2204-8306-0 www.miltenyibiotec.com

Company Overview

Miltenyi Biotec is a biotechnology company focused on developing products and integrated solutions for biomedical research, cell and gene therapy, and clinical applications. It is widely recognized for its Magnetic-Activated Cell Sorting (MACS) technology used in cell separation and analysis. Its portfolio includes flow cytometry systems, molecular analysis tools, cell culture platforms, automated cell processing technologies, and GMP manufacturing solutions. It offers a PBMC isolation kit in the peripheral blood mononuclear cells market. Miltenyi Biotec supports researchers, hospitals, and biopharmaceutical companies across areas such as immunology, oncology, stem cell research, neuroscience, and regenerative medicine.

Miltenyi Biotec operates through 27 global locations with employees from over 75 countries. It offers more than 21,000 products supporting translational research, cell analysis, and cell therapy manufacturing applications worldwide.

MILTENYI BIOTEC In Reports

Global Peripheral Blood Mononuclear Cells (PBMCs) Market

Analyze the global Peripheral Blood Mononuclear Cells Market by product type, application and technique, covering immunology, oncology, vaccine development and forecasts to 2031.

Cell and Gene Therapy Tools and Reagents: Global Markets

BCC Research detailed report on Cell and Gene Therapy Tools and Reagents Market covered are North America, Europe, Asia-Pacific and the Rest of the World (RoW). For market estimates, data has been provided for 2024 as...

Cell Therapy Processing: Global Markets and Technologies

BCC Research detailed report on cell therapy processing market includes global revenue ($ Million) for the base year data of 2024 and estimated data for the forecast period 2025 through 2030.

Company's Business Segments

  • Cell and Gene Therapy (CGT) : The company offers cell separation technologies, cell analysis solutions, cell sorting platforms, cell and gene therapy manufacturing solutions, cell culture media and reagents, molecular biology and genomics products, immunology and stem cell research products, bioprocessing instruments and software, technical and laboratory services, and clinical and translational research solutions.

Applications/End User Industries

  • Immunology
  • Stem Cell Research
  • Oncology
  • Cell and Gene Therapy
  • Neuroscience
  • Cardiovascular
  • Immuno-Oncology
  • Hematopoietic
  • Mesenchymal Stem Cells
  • Tumor Cell
  • Isolation
  • Neurons
  • Neuroscientists
  • Microglia
  • Life Sciences
AI Sentiment